Global Pharmaceuticals & Biotech Big Green Snowflakes

Eris Lifesciences

Market Cap: ₹235.5b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Hanmi Pharm

Market Cap: ₩3.9t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

JW Pharmaceutical

Market Cap: ₩511.4b

Manufactures and sells medicines and medical supplies in Japan and internationally.

BLIS Technologies

Market Cap: NZ$21.7m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.

Orchid Pharma

Market Cap: ₹36.2b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.

Genesis IBRC India

Market Cap: ₹519.2m

Does not have significant operations.

Pulike Biological Engineering

Market Cap: CN¥4.9b

Engages in the research and development, production, and marketing of veterinary biological products and drugs.

CellSource

Market Cap: JP¥11.8b

Engages in the regenerative medicine-related businesses in Japan.

Renata

Market Cap: ৳57.9b

Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.

AC Immune

Market Cap: US$212.7m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Arcutis Biotherapeutics

Market Cap: US$1.9b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Quantum-Si

Market Cap: US$216.7m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

United Therapeutics

Market Cap: US$17.2b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

2invest

Market Cap: €72.2m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

Sartorius Stedim Biotech

Market Cap: €16.9b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Regeneron Pharmaceuticals

Market Cap: US$58.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Domesco Medical Import - Export

Market Cap: ₫2.2t

Engages in the research and development, manufacturing, marketing, and trading of pharmaceutical products, herbal-origin medicines, functional foods, purified drinking water, and herbal-based beverages in Vietnam.

Northeast Pharmaceutical Group

Market Cap: CN¥8.1b

Engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China.

Bioray Biotech

Market Cap: NT$884.6m

Engages in the research and development, manufacture, and sale of biological and health supplement products.

Formosa Laboratories

Market Cap: NT$8.2b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Sichuan Huiyu Pharmaceutical

Market Cap: CN¥10.3b

Research and develops, produces, and sells anti-tumor and injection drugs in China and internationally.

Qianjiang Yongan Pharmaceutical

Market Cap: CN¥5.2b

Qianjiang Yongan Pharmaceutical Co., Ltd.

Genscript Biotech

Market Cap: HK$37.9b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Laurus Labs

Market Cap: ₹475.4b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

SMS Pharmaceuticals

Market Cap: ₹20.9b

Manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally.

Changchun BCHT Biotechnology

Market Cap: CN¥9.5b

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.

Cell Biotech

Market Cap: ₩88.1b

A biotechnology company, develops lactic acid bacteria products in South Korea and internationally.

Zhejiang Int'l GroupLtd

Market Cap: CN¥6.0b

Engages in the wholesale and retail of pharmaceuticals and medical devices.

PTC Therapeutics

Market Cap: US$4.6b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Birzeit Pharmaceuticals

Market Cap: US$139.6m

Manufactures and trades in various medicines in the Palestinian Authority.

Mineralys Therapeutics

Market Cap: US$2.5b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Market Cap: ₺50.7b

A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

biote

Market Cap: US$155.3m

Operates in practice-building business within the hormone optimization space.

Rocket Pharmaceuticals

Market Cap: US$348.5m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Protalix BioTherapeutics

Market Cap: US$126.8m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.